Company News

Share this article:

Abbott Animal Health announced a partnership with Velcera, a specialty pharma focused on pet health, to market a canine pain management product delivered in a transmucosal mist form. The Promist technology delivers the active ingredient through a fine mist to the inside cheek or oral cavity of the animal, where it's absorbed through the mucous membranes of the mouth.

Algos Therapeutics changed its name to Algos Preclinical Services, after a shift from developing pain therapy products into pure contract research as a CRO for drug discovery and product development. The company also launched a redesigned website created through a partnership with MVP Marketing + Design.

Concord, MA-based Emerson Hospital tapped Boston-based Partners+Simons to develop a "digital lobby" website for the hospital. The "next-generation" website will be used to emphasize the hospitals dedication to its patients, and to build the brand online, according to a company statement.   


Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Payment database confounds doctors

ProPublica reports that doctors are struggling with a time-intensive registration process and are getting an error message that CMS says is not an error message.

Gilead's idelalisib hat trick

The FDA greenlighted the drug for three cancers.

Shire expands rare disease reach

A $225-million deal with US biotech ArmaGen gives Shire worldwide commercialization rights to an experimental enzyme replacement therapy.